Somehow, the public has got it into its head that FDA should inspect all the world's drug plants. Aren't there better ways to ensure the safety of imported drugs?
Nov 1, 2008
By:
Patrick Clinton
|
Is FDA's MO in foreign inspections too broken to fix?
Oct 1, 2008
By:
Patrick Clinton
|
A vision of pharma's next business model is starting to emerge. But how do we get from here to there?
Sep 1, 2008
By:
Patrick Clinton
|
The United States makes the best medicines in the world. In days to come, that could be a problem.
Aug 1, 2008
By:
Patrick Clinton
|
FDA preemption is a hot issue for pharma, and it's likely to get hotter. But it's the wrong issue.
It's not that I disagree with the Obama and McCain healthcare proposals. It's that there's nothing actually there to disagree with.
Jul 1, 2008
By:
Patrick Clinton
|
It's not that I disagree with the Obama and McCain healthcare proposals. It's that there's nothing actually there to disagree with
Jun 1, 2008
By:
Patrick Clinton
|
The great debate on DTC advertising is heating up again. We're going to be hearing a lot about fair balance and risk communication and costs. But what about the patients?
Apr 1, 2008
By:
Patrick Clinton
|
The real question in the Baxter heparin scandal is not who's guilty but whether pharma can get reliable results from a country in chaos
Apr 1, 2008
By:
Patrick Clinton
|
The real question in the Baxter heparin scandal is not who's guilty but whether pharma can get reliable results from a country in chaos
Mar 1, 2008
By:
Patrick Clinton
|
For pharma to function, it needs a whole network that commands trust. The only alternative is the sort of regulation by mass tort that we've been sliding into in recent years
